Sunday, May 28, 2023

Managing T2DM in Patient with Inadequate Glycemic Control on Low Dose Metformin

Recent studies have shown that combination therapy with glimepiride/metformin offers significant advantages over metformin up-titration alone in reducing glycated hemoglobin (HbA1c) levels.
MedSynapse Community of Doctors MedSynapse
Managing T2DM in Patient with Inadequate Glycemic Control on Low Dose Metformin

For T2DM patients on low-dose metformin with inadequate glycemic control, the decision between increasing metformin dosage or introducing glimepiride/metformin combination therapy demands thoughtful evaluation.

Quick options for you (click to select) :
Considering the available options for treating type 2 diabetic patients, which treatment approach would you prefer to reduce glycated hemoglobin (HbA1c) levels?
Metformin up-titration alone
Combination therapy with glimepiride/metformin
Adding another oral antidiabetic medication to metformin
Insulin therapy initiation
Click to Share Opinion
This email is intended for Dr. Renukaprasad A R Unsubscribe / Change your email preferences.

© 2023 MedSynapse, USA, Singapore, India, Dubai

No comments:

Post a Comment